Exelixis: Drug Development and Pricing – Six Business Analyses

How do scientific value, patient access and partner economics connect across Exelixis's oncology business model?

The Exelixis Business Model Canvas brings together all nine building blocks: customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partnerships and cost structure. In oncology, the relevant customer ecosystem can include patients, prescribers, treatment centers, payers and collaborators, each with different evidence and access needs. The canvas helps examine how research capabilities, clinical development, regulatory work and commercialization activities support the value offered. It also creates room to assess how companion-diagnostic relationships could support biomarker-guided patient selection and how milestone-based collaboration structures may affect risk sharing, spending and potential returns.

• Value pathway. Trace how treatment evidence and patient-selection considerations may move through clinical, payer and specialist-care channels.
• Economic connections. Link revenue-stream questions to development costs, key resources and partnerships rather than viewing each block in isolation.
• Team alignment. Populate the Excel canvas during planning sessions and use the detailed Word analysis to record the rationale behind each business-model connection.

How can Exelixis align its oncology offering, access logic, care channels and communications with a regulated specialist market?

The Exelixis Marketing Mix examines Product, Price, Place and Promotion in the context of cancer treatment. Product analysis considers the therapeutic proposition, supporting evidence and potential role within clinical practice. Price is not simply a list amount in oncology; it raises questions about reimbursement, demonstrated value, affordability and the economics of treatment access. Place considers how therapies reach specialist oncology settings through appropriate distribution and care pathways. Promotion focuses on compliant, evidence-led communication to healthcare professionals and other relevant stakeholders. Looking across the 4Ps helps avoid treating commercial execution as separate from the clinical and access conditions that shape patient availability.

• Offering fit. Explore how clinical differentiation, indication context and treatment experience can influence the product story.
• Access route. Compare the roles of oncology practices, provider systems, payers and distribution arrangements in reaching appropriate patients.
• Go-to-market review. Use the Excel framework to organize 4Ps questions and the Word analysis to build a more detailed discussion of evidence, access and communication choices.

How can Exelixis distinguish internal capabilities and constraints from external oncology opportunities and threats?

The Exelixis SWOT analysis separates internal Strengths and Weaknesses from external Opportunities and Threats. This distinction matters for an oncology biotech company because scientific, development and commercial capabilities are not the same as market conditions, reimbursement pressure or emerging treatment alternatives. The framework helps assess supported strengths such as relevant organizational capabilities only where evidence justifies them, while identifying possible weaknesses or constraints that merit closer review. Opportunities may arise from unmet patient needs, new evidence paths or partnership possibilities; threats may include competitive, regulatory, access or execution risks. It is designed to turn a broad company discussion into a more disciplined set of strategic questions rather than presenting unverified themes as settled findings.

• Internal diagnosis. Distinguish resources, expertise and operating constraints from conditions outside the company's direct control.
• Strategic fit. Test whether possible opportunities can be pursued with available capabilities while recognizing relevant external threats.
• Action agenda. Use the Excel matrix to prioritize discussion points and the Word analysis to explain why each item belongs in its correct internal or external category.